TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05306171

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online training for healthcare professionals
Description: The online training (4 modules) will use the technique of hybrid learning, combining meetings that will require the presence of participants and mediator at the same time and platform (live) with recorded meetings (interviews with experts) that will be watched by the participants at any time (from a distance).~Module 1: Self Care; Module 2: Stress and anxiety management; Module 3: Relationships; Module 4: Communication.
Study: NCT05514236

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality Therapy
Description: Participants will be given the virtual reality device (a headset) with immersive video content for use during the hysteroscopy. Designated moving objects with sound will be broadcasted on the screen to the participant in this group.~Participant can adjust the volume of the sound according to her comfort.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Therapy
Description: Participants will be given a headphone playing either classical light music or 'POP' songs according to their option during the hysteroscopy.~Participant can adjust the volume of the music according to her comfort.
Study: NCT05380323

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3541105
Description: Administered SC.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3541105
Description: Administered SC.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3541105
Description: Administered SC.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC.
Study: NCT06138119

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: stereotype threat manipulation
Description: Stereotype threat is the thought that a person will be negatively evaluated and judged regarding a negative stereotype that belongs to the group to which he/ she belongs. Stereotype threat manipulation will be performed on the male and female participants in the experimental group just before they are taken into the testing room. For manipulation, the following sentences will be said to the participants in the experimental group: We aim to compare fiberoptic intubation performance between male and female anesthesiologists. Additionally, we are investigating whether the high inclination of males towards computer games has any impact on their fiberoptic intubation success. The other participants (Control Group) will not be given any prior information.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: stereotype threat manipulation
Description: Stereotype threat is the thought that a person will be negatively evaluated and judged regarding a negative stereotype that belongs to the group to which he/ she belongs. Stereotype threat manipulation will be performed on the male and female participants in the experimental group just before they are taken into the testing room. For manipulation, the following sentences will be said to the participants in the experimental group: We aim to compare fiberoptic intubation performance between male and female anesthesiologists. Additionally, we are investigating whether the high inclination of males towards computer games has any impact on their fiberoptic intubation success. The other participants (Control Group) will not be given any prior information.
Study: NCT05811026

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Periorbital rejuvenation with a 1927 nm diode laser treatment (2-week interval)
Description: * Visit 1 (W0): Clear + Brilliant™ Permea device periorbital treatment~* Visit 2 (W2): Clear + Brilliant™ Permea device periorbital treatment~* Visit 3 (W4): Clear + Brilliant™ Permea device periorbital treatment~* Visit 4 (W8): Four weeks after the third treatment, a follow-up assessment will be performed

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Periorbital rejuvenation with a 1927 nm diode laser treatment (4-week interval)
Description: * Visit 1 (W0): Clear + Brilliant™ Permea device periorbital treatment~* Visit 2 (W4): Clear + Brilliant™ Permea device periorbital treatment~* Visit 3 (W8): Clear + Brilliant™ Permea device periorbital treatment~* Visit 4 (W12): Four weeks after the third treatment, a follow-up assessment will be performed
Study: NCT05703685

Intervention type: DRUG
Group type: OTHER
Intervention: 18F-PF-06445974
Description: Injected IV followed by PET scanning
Study: NCT06348810

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dual-task training
Description: The dual-task training is a combination of cognitive tasks and motor tasks which is done simultaneously or at the same time.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive training
Description: Participants only receive cognitive tasks

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motor training
Description: Participants only receive motor tasks

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: assist participants with activities of daily living, medication management, and social activities (such as singing, watching television).
Study: NCT05271357

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bilateral TMS
Description: Stimulation begins with continuous TBS to the right dorsolateral prefrontal cortex (DLPFC) (120 seconds of uninterrupted bursts; 600 pulses per session) followed by intermittent TBS to the left DLPFC (2 seconds on and 8 seconds off; 600 pulses per session); total duration of 3 min 9 seconds per hemisphere.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Unilateral TMS
Description: Stimulation involves only intermittent TBS to the left DLPFC (2 seconds on and 8 seconds off; 600 pulses per session); total duration of 3 min 9 seconds.
Study: NCT05871957

Intervention type: DRUG
Intervention: Vitamin D Drops
Description: Supplement 2000IU of vitamin D, no matter the brand or manufacturer for 1 month.
Study: NCT06518967

Intervention type: DIAGNOSTIC_TEST
Intervention: analytical performance study
Description: analytical performance study on left-over samples with the SiMoT IVD system for in vitro diagnostic tests

Intervention type: DIAGNOSTIC_TEST
Intervention: analytical performance study
Description: analytical performance study on left-over samples with the SiMoT IVD system for in vitro diagnostic tests
Study: NCT05750134

Intervention type: OTHER
Intervention: OBPLUS Clinical Database : data analysis
Description: The data processed relates to patients cared for in the Hepato-gastroenterology and nutrition department of the Antoine Béclère Hospital at the Assistance Publique - Hôpitaux de Paris (AP-HP. All of the clinical and paraclinical data are collected during the visits and entered into the OBPLUS database (database registered in the AP-HP register). These data will be analyzed in order to identify the predictive factors of the effectiveness of the fundo-plication.

Intervention type: OTHER
Intervention: Biological collection Liver, bile ducts and pancreas: sample analysis
Description: The samples (plasma, serum, saliva, stool) collected during the samples taken as part of the patient's care were the subject of a biological collection Liver, bile ducts and pancreas. These samples will be analyzed in order to identify the predictive factors of the effectiveness of the fundo-plication.
Study: NCT06278558

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interviews with a psychologist/psychiatrist
Description: All patients with a high score (≥11) on the HADS anxiety and/or depressive symptoms scale and who are not already receiving known psychological treatment or treatment mentioned in the file will be contacted by telephone by the investigator or a qualified person designated by him/her in order to conduct a telephone interview with the patient and refer him/her to a psychologist or psychiatrist if necessary. The number and percentage of consultations with a psychologist or psychiatrist following this telephone interview will be calculated in order to highlight the benefits of such a practice (HADS assessment + telephone interview with +/- referral) for earlier and easier referral. Depending on the number of patients contacted, consideration may be given to testing the effect of this approach on post-traumatic development.
Study: NCT01363713

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DE-114 ophthalmic solution
Study: NCT04740099

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SOONER Video & Kit
Description: A brief animated video including basic instructions for opioid overdose response accompanied by a Naloxone kit with an info graphic.

Intervention type: OTHER
Group type: OTHER
Intervention: Standard of Care
Description: A handout including a map and list of locations offering this service.
Study: NCT05682586

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: umbilical cord mesenchymal stem cells
Description: Participants will receive two doses of UC-MSCs treatment, each dose will contain 1\*10\^6 cells/kg suspended in 100 ml albumin solution.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: paxlovid
Description: Participants will receive standard dose of paxlovid therapy, which contains 300mg namatevir and 100mg litonavir twice a day for a total course of 5 days.
Study: NCT06175000

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cognitive Assessment
Description: Ancillary studies to evaluate neurocognitive function at study entry and at 2 years after study entry.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Assessment
Description: Ancillary studies to evaluate neurocognitive function at study entry and at 2 years after study entry.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Obinutuzumab
Description: Given IV

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality of Life Assessment
Description: Ancillary studies to evaluate quality of life at study entry and at 2 years after study entry.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality of Life Assessment
Description: Ancillary studies to evaluate quality of life at study entry and at 2 years after study entry.
Study: NCT06242782

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: VRA + d-PTFE membrane
Description: VRA using a 50/50 particulate bone mix (xenograft+ autograft) + Ti-Reinforced d-PTFE membrane

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: VRA + e-PTFE membrane
Description: VRA using a 50/50 particulate bone mix (xenograft+ autograft) + Ti-Reinforced e-PTFE membrane

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: VRA + customised Ti-mesh
Description: VRA using a 50/50 particulate bone mix (xenograft+ autograft) + 3D printed Titanium mesh

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: VRA + RPM
Description: VRA using a 50/50 particulate bone mix (xenograft+ autograft) + Reinforced PTFE mesh
Study: NCT05721924

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pericapsular nerve group (PENG) block
Description: In PENG group, the patient will be given PENG block 30mls of 0.2% ropivacaine
Study: NCT05521217

Intervention type: DIAGNOSTIC_TEST
Intervention: MyotonPRO
Description: Evaluation of biomechanics and viscoelastic properties of posture muscle in children with Spinal Muscular Atrophy.~The biomechanical and viscoelastic properties of the posture muscle in children with Spinal Muscular Atrophy. will be measured with the MyotonPRO device.

Intervention type: DIAGNOSTIC_TEST
Intervention: MyotonPRO
Description: Evaluation of biomechanics and viscoelastic properties of posture muscle in children with Spinal Muscular Atrophy.~The biomechanical and viscoelastic properties of the posture muscle in children with Spinal Muscular Atrophy. will be measured with the MyotonPRO device.
Study: NCT05721924

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Supra-inguinal fascia iliaca compartment (S-FICB) block
Description: Patients in group B (S-FICB group) will be supra-inguinal fascia iliaca compartment block 30mls of 0.2% ropivacaine
Study: NCT05353166

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN5381
Description: Single dose administered via IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN5381
Description: Single dose administered via IV infusion
Study: NCT06278038

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toludesvenlafaxine hydrochloride sustained-release tablets
Description: 80 mg or 120 mg or 160 mg orally once daily dosing for 8 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Venlafaxine hydrochloride sustained-release tablets
Description: 75 mg or 150 mg or 225 mg orally once daily dosing for 8 weeks
Study: NCT04854564

Intervention type: BEHAVIORAL
Intervention: Prehabilitation intervention
Description: The investigators will identify participants' perceived important information to develop a prehabilitation intervention in this study. Prehabilitation intervention consisting of physical activities, nutrition, and stress management.

Intervention type: BEHAVIORAL
Intervention: Caregiver intervention
Description: The investigators will provide caregivers with variety of educational resources for patients experiencing ESLD.
Study: NCT05982821

Intervention type: OTHER
Intervention: Artificial Intelligent
Description: Artificial intelligence assisted radiologists to extract ultrasound features of thyroid nodules.

Intervention type: OTHER
Intervention: Artificial Intelligent
Description: Artificial intelligence assisted radiologists to extract ultrasound features of thyroid nodules.

Intervention type: OTHER
Intervention: Artificial Intelligent
Description: Artificial intelligence assisted radiologists to extract ultrasound features of thyroid nodules.
Study: NCT06140121

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality Physical Therapy
Description: Participants are allowed to freely choose one game from the game list. Participant will be asked to wear a validated activity tracker - ActiGraph. Baseline heart rate will be collected for 1 minute. Participants will be wearing the ActiGraph during Physical Therapy session. Participants receiving VR intervention will be instructed to wear an Oculus Quest 2 headset (Meta, Inc., Menlo Park, CA) and participate in VR applications under the supervision of the physical therapist.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality Physical Therapy
Description: Participants are allowed to freely choose one game from the game list. Participant will be asked to wear a validated activity tracker - ActiGraph. Baseline heart rate will be collected for 1 minute. Participants will be wearing the ActiGraph during Physical Therapy session. Participants receiving VR intervention will be instructed to wear an Oculus Quest 2 headset (Meta, Inc., Menlo Park, CA) and participate in VR applications under the supervision of the physical therapist.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Traditional Physical Therapy
Description: Participants will receive traditional Physical Therapy sessions (standard care) under the supervision of the accredited physical therapist. Participants will be wearing the Actigraph during Physical Therapy session. Participants will perform regular physical exercise, such as 20 minutes walking or biking on a stationary bike, under the supervision of a physical therapist.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Traditional Physical Therapy
Description: Participants will receive traditional Physical Therapy sessions (standard care) under the supervision of the accredited physical therapist. Participants will be wearing the Actigraph during Physical Therapy session. Participants will perform regular physical exercise, such as 20 minutes walking or biking on a stationary bike, under the supervision of a physical therapist.
Study: NCT05353166

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN5381
Description: Single dose administered via IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo
Description: Single dose administered via IV infusion
Study: NCT04771793

Intervention type: BEHAVIORAL
Intervention: new physical restraint protocols
Description: new physical restraint protocols

Intervention type: BEHAVIORAL
Intervention: new physical restraint protocols
Description: new physical restraint protocols
Study: NCT05178225

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: ubiquinol (reduced coenzyme Q10)
Description: supplementation with ubiquinol (reduced coenzyme Q10), in a daily dose of 2x100 mg. one morning after breakfast, and second dose after dinner.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: mountain spa rehabilitation
Description: special spa rehabilitation in the mountain High Tatras; Functional capacity of the lungs (6MWT) at before and after 16-18 days of rehabilitation, Borg scale for dyspnea and oxygen saturation SpO2 (%) were monitored.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: mountain spa rehabilitation
Description: special spa rehabilitation in the mountain High Tatras; Functional capacity of the lungs (6MWT) at before and after 16-18 days of rehabilitation, Borg scale for dyspnea and oxygen saturation SpO2 (%) were monitored.

Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: 2x14 ml of peripheral blood collected in a tube with anticoagulant
Description: 2x14 ml of peripheral blood collected in a tube with anticoagulant

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: 2x14 ml of peripheral blood collected in a tube with anticoagulant
Description: 2x14 ml of peripheral blood collected in a tube with anticoagulant

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: 2x14 ml of peripheral blood collected in a tube with anticoagulant
Description: 2x14 ml of peripheral blood collected in a tube with anticoagulant
Study: NCT05353166

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo
Description: Single dose administered via IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo
Description: Single dose administered via IV infusion
Study: NCT05419245

Intervention type: OTHER
Intervention: Guided Health History for Freeman-Burian Syndrome Questionnaire
Description: Completed during the interview. The Guided Health History for Freeman-Burian Syndrome Questionnaire is a guided interview form that will be used to assess diagnosis, problems, treatments, and outcomes.

Intervention type: OTHER
Intervention: Guided Health History for Freeman-Burian Syndrome Questionnaire
Description: Completed during the interview. The Guided Health History for Freeman-Burian Syndrome Questionnaire is a guided interview form that will be used to assess diagnosis, problems, treatments, and outcomes.

Intervention type: OTHER
Intervention: Guided Health History for Freeman-Burian Syndrome Questionnaire
Description: Completed during the interview. The Guided Health History for Freeman-Burian Syndrome Questionnaire is a guided interview form that will be used to assess diagnosis, problems, treatments, and outcomes.

Intervention type: OTHER
Intervention: Guided Health History for Freeman-Burian Syndrome Questionnaire
Description: Completed during the interview. The Guided Health History for Freeman-Burian Syndrome Questionnaire is a guided interview form that will be used to assess diagnosis, problems, treatments, and outcomes.

Intervention type: OTHER
Intervention: Freeman-Burian syndrome Semi-Structured Quality of Life Interview
Description: Completed during the interview. Freeman-Burian syndrome Semi-Structured Quality of Life Interview is a quality of life interview for Freeman-Burian syndrome, taking into consideration individual's total health.

Intervention type: OTHER
Intervention: Freeman-Burian syndrome Semi-Structured Quality of Life Interview
Description: Completed during the interview. Freeman-Burian syndrome Semi-Structured Quality of Life Interview is a quality of life interview for Freeman-Burian syndrome, taking into consideration individual's total health.

Intervention type: OTHER
Intervention: Freeman-Burian syndrome Semi-Structured Quality of Life Interview
Description: Completed during the interview. Freeman-Burian syndrome Semi-Structured Quality of Life Interview is a quality of life interview for Freeman-Burian syndrome, taking into consideration individual's total health.

Intervention type: OTHER
Intervention: Freeman-Burian syndrome Semi-Structured Quality of Life Interview
Description: Completed during the interview. Freeman-Burian syndrome Semi-Structured Quality of Life Interview is a quality of life interview for Freeman-Burian syndrome, taking into consideration individual's total health.
Study: NCT05311293

Intervention type: DIAGNOSTIC_TEST
Intervention: Endoscopy
Description: Observe the extent of colonic lesions and obtain intestinal mucosal samples

Intervention type: DIAGNOSTIC_TEST
Intervention: Endoscopy
Description: Observe the extent of colonic lesions and obtain intestinal mucosal samples

Intervention type: DIAGNOSTIC_TEST
Intervention: Endoscopy
Description: Observe the extent of colonic lesions and obtain intestinal mucosal samples
Study: NCT06399679

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rivastigmine
Description: Rivastigmine 3mg by mouth once, followed by rivastigmine 1.5mg by mouth every 1 hour as needed for ongoing delirium or agitation (at the discretion of the treating physician), for a maximum of three doses

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching oral placebo by mouth once, followed by placebo by mouth every 1 hour as needed for ongoing delirium or agitation (at the discretion of the treating physician), for a maximum of three doses
Study: NCT05936333

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biological collection
Description: up to 25 mL of blood collection for the adults and saliva collection for the minor at inclusion, and placenta collection at childbirth

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biological collection
Description: up to 25 mL of blood collection for the adults and saliva collection for the minor at inclusion, and placenta collection at childbirth

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Biological collection
Description: up to 25 mL of blood collection for the adults and saliva collection for the minor at inclusion, and placenta collection at childbirth
Study: NCT06216730

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Endoscopic papillectomy
Description: patients undergoing endoscopic papillectomy will be included and treated according to the study algorithm.~* A papillary adenoma (abnormal tissue growth/ tumour at junction of bile duct \& intestines) will be removed completely by cutting \& removing abnormal tissue growth using a flexible tube containing a camera through the mouth.~* After the procedure you will be admitted in the hospital for at least 24 hours for observation,~* You will be asked to use medications which decrease acid production (PPIs- proton pump inhibitors) in stomach for 2 weeks to decrease the risk of bleeding.